Abstract
Gene therapy is an important tool in the treatment of many diseases involving malfunctioning of deoxyribo nucleic acid (DNA). Development of various techniques for efficiently transferring and expression of recombinant DNA or ribonucleic acid (RNA) at target site is a significant challenge. Viral vectors which have been used classically have a number of restrictions due to their induced toxicity and immunogenicity, the limited size of DNA that can be carried, the lack of specificity and the high cost of production. To overcome these problems nonviral vectors like nanoparticles, dendrimers, molecular conjugates, liposomes, microbubbles etc. are being explored. This review encompasses the details of these nonviral vectors.
Keywords: Efficiency, gene delivery, nonviral, transfection, vector, viral, Nanoparticles, Dendriplexes, Molecular Conjugates, Microbubbles
Current Drug Therapy
Title: Advanced Vectors for Gene Delivery
Volume: 6 Issue: 4
Author(s): Rajashree Hirlekar, Pramod Jagtap and Vilasrao Kadam
Affiliation:
Keywords: Efficiency, gene delivery, nonviral, transfection, vector, viral, Nanoparticles, Dendriplexes, Molecular Conjugates, Microbubbles
Abstract: Gene therapy is an important tool in the treatment of many diseases involving malfunctioning of deoxyribo nucleic acid (DNA). Development of various techniques for efficiently transferring and expression of recombinant DNA or ribonucleic acid (RNA) at target site is a significant challenge. Viral vectors which have been used classically have a number of restrictions due to their induced toxicity and immunogenicity, the limited size of DNA that can be carried, the lack of specificity and the high cost of production. To overcome these problems nonviral vectors like nanoparticles, dendrimers, molecular conjugates, liposomes, microbubbles etc. are being explored. This review encompasses the details of these nonviral vectors.
Export Options
About this article
Cite this article as:
Hirlekar Rajashree, Jagtap Pramod and Kadam Vilasrao, Advanced Vectors for Gene Delivery, Current Drug Therapy 2011; 6 (4) . https://dx.doi.org/10.2174/157488511798109600
DOI https://dx.doi.org/10.2174/157488511798109600 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Potential of T Cell Immunoglobulin and Mucin-Domain Containing-3
(Tim-3) in Designing Novel Immunotherapy for Bladder Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Bioactive Secondary Metabolites from Endophytic Fungi
Current Medicinal Chemistry Natural Sesquiterpenoids as Cytotoxic Anticancer Agents
Mini-Reviews in Medicinal Chemistry Accessing Cancer Metabolic Pathways by the Use of Microarray Technology
Current Pharmaceutical Design Stem Cell-Mediated Exon Skipping of the Dystrophin Gene by the Bystander Effect
Current Gene Therapy Pharmacological Activity of Natural Non-glycosylated Triterpenes
Mini-Reviews in Organic Chemistry uPAR as Anti-Cancer Target: Evaluation of Biomarker Potential, Histological Localization, and Antibody-Based Therapy
Current Drug Targets The Human L1 Element: A Potential Biomarker in Cancer Prognosis, Current Status and Future Directions
Current Molecular Medicine Lemon Juice as a Biocatalyst Under Ultrasound Irradiation: Synthesis and Pharmacological Evaluation of 2-amino 1,3,4-thiadiazoles
Anti-Cancer Agents in Medicinal Chemistry Preface
Current Proteomics Local Recurrence vs Radiotherapy-Induced Edema in Advanced Laryngeal Carcinoma: Is FDG PET/CT Up to the Challenge?
Current Molecular Imaging (Discontinued) Recent Development in Targeting PI3K-Akt-mTOR Signaling for Anticancer Therapeutic Strategies
Anti-Cancer Agents in Medicinal Chemistry Review of the Phytochemistry and Biological Activity of Cissus incisa Leaves
Current Topics in Medicinal Chemistry Inhibitors of HIV-1 Protease: Current State of the Art 10 Years After their Introduction. From Antiretroviral Drugs to Antifungal, Antibacterial and Antitumor Agents Based on Aspartic Protease Inhibitors
Current Medicinal Chemistry Modulators of Protein-Protein Interactions – Novel Approaches in Targeting Protein Kinases and Other Pharmaceutically Relevant Biomolecules
Current Topics in Medicinal Chemistry The Relationship Between Oncogene Expression and Clinical Outcome in Endometrial Carcinoma
Current Cancer Drug Targets Heparanase as a Target in Cancer Therapy
Current Cancer Drug Targets L-Sulforaphane Confers Protection Against Oxidative Stress in an In Vitro Model of Age-Related Macular Degeneration
Current Molecular Pharmacology miR-203 Suppresses the Proliferation and Metastasis of Hepatocellular Carcinoma by Targeting Oncogene ADAM9 and Oncogenic Long Non-coding RNA HULC
Anti-Cancer Agents in Medicinal Chemistry Bioinformatics Analysis of Functional Relations Between CNPs Regions
Current Bioinformatics